As the leader in syndromic testing,
bioMérieux presents its latest revolutionary offer
in Point-of-Care testing with BIOFIRE® SPOTFIRE®,
a new solution designed with clinicians and their patients in mind.
SYNDROMIC TESTING
FOR POINT-OF-CARE
Due to the similarity of infectious diseases caused by multiple pathogens, diagnosis based on clinical symptoms alone is difficult during a patient appointment.
Rapid and comprehensive onsite results may reduce the need for follow-up appointments, swabbing, and testing. Syndromic testing from BIOFIRE® SPOTFIRE® Solution can help inform timely treatment decisions and may reduce the use of unnecessary antibiotics.
BIOFIRE® SPOTFIRE® SYSTEM1
bioMérieux's latest innovation in molecular infectious disease diagnostics,
designed for Point-of-Care testing.
Small and Modular
Minimal benchtop space required and vertically scale up for a customizable throughput
Fully automated
Sample to Result system with bi-directional connectivity (POCT01-A2) for effortless data transfer and seamless reporting
Boosted flexibility
Modules random access to run up to 4 tests at the same time
Easy to use
Intuitive system interface and streamlined workflow allowing usage by healthcare professionals, at any time, in healthcare settings
| 1 |  |
Product availability varies by country. Consult your bioMérieux representative.
BIOFIRE® SPOTFIRE®
RESPIRATORY/SORE THROAT (R/ST) PANEL2
1 PCR Test. 2 Uses. 15 Targets. ~15 Minutes.
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel is a syndromic multiplex PCR test developed for Point-of-Care testing.
Respiratory tract infections are a significant cause of morbidity and mortality, and they exact a huge economic cost across the world.
Testing for more than flu, RSV, and SARS-CoV-2 with one test provides healthcare professionals with the full picture and may impact patient therapy and management decisions.
For more info about the panel menu
| 2 |  |
Product availability varies by country. Consult your bioMérieux representative.
